To address the contribution of TTC17/RAP1/CDC42 activation to metastasis in patients with BC, we detected the protein expression of TTC17 and CDC42 in a large cohort of nonmetastatic and metastatic primary breast tumors together with their metastatic lymph node tissues. Here, RAP1A is linked to breast neoplasm.